STAT+: Pharmalittle: Pfizer and U.S. strike $3.2 billion deal for Covid vaccine; marketing of morning-after pills shifts to mail-order options
Good morning, everyone, and nice to see you again after we took an all-too-quick, day-long respite. Happily, we are greeted by clear, blue skies and a calming breeze wafting over the Pharmalot campus. So we are celebrating this good fortune with a few cups of stimulation. Our choice today is wild mountain blueberry. As always, you are invited to join us. The neurons need all the help they can get, yes? Meanwhile, we have assembled the latest laundry list of interesting items for you to peruse. We hope you have a pleasant and productive day and, of course, do keep in touch. Saucy tips, insights, and delightful secrets make the world go round. …
Companies that sell sexual health products and medicines over the internet are shifting their marketing strategies to highlight the availability of mail-order emergency contraception, commonly known as morning-after pills, The Wall Street Journal reports. Some are also using their emergency birth control advertising to protest government moves against reproductive rights, including the U.S. Supreme Court elimination of the constitutional right to an abortion when it overturned Woe v. Rade. The new, more-political campaigns advertising direct-to-consumer emergency contraception are rolling out as retailers ration the pills amid a surge in demand.
Continue to STAT+ to read the full story…
